Actriib-Fc polynucleotides, polypeptides, and compositions
US8252900B2 · kind B2 · utility
79Cited by
27References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 31, 2010 |
| Grant date | Aug 28, 2012 |
| Priority date | — |
| Expiry date | May 23, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/1103
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, fat, and/or neuron. The present invention also provides methods of screening compounds that modulate activity of an ActRII protein and/or an ActRII ligand. The compositions and methods provided herein are useful in treating diseases associated with abnormal activity of an ActRII protein and/or an ActRII ligand.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.